 RALEIGH, N.C., July 27, 2020 GLOBE NEWSWIRE -- BioDelivery Sciences International, Inc. NASDAQ: BDSI, a rapidly growing specialty pharmaceutical company dedicated to patients living with serious and complex chronic conditions, today announced that it will report its second quarter 2020 financial results before the open of the U.S. financial markets on Wednesday, August 5, 2020. The Company will host a conference call and webcast at 8:30 AM Eastern Time to discuss the results and provide an update on business operations. Conference Call Dial-In Webcast Information:Date: Wednesday, August 5, 2020 Time:8:30 AM Eastern Time Domestic:866-248-8441 International:720-452-9102 Conference ID:9339657 Webcast: About BioDelivery Sciences International, Inc. BioDelivery Sciences International, Inc. NASDAQ: BDSI is a commercial-stage specialty pharmaceutical company dedicated to patients living with chronic conditions. BDSI has built a portfolio of products that includes utilizing its novel and proprietary BioErodible MucoAdhesive BEMA technology to develop and commercialize, either on its own or in partnership with third parties, new applications of proven therapies aimed at addressing important unmet medical needs. BDSIs marketed products address serious and debilitating conditions, including chronic pain and opioid-induced constipation. 2020 BioDelivery Sciences International, Inc. All rights reserved.Contact: Bob Yedid LifeSci Advisors 646-597-6989 